{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-017025","form_type":"8-K","ticker":"SKIN","cik":"0001818093","company_name":"SkinHealth Systems Inc.","filed_at":"2023-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.818493+00:00","generated_at":"2026-06-15T06:56:26.511586+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BeautyHealth Q1 net sales $86.3M (+14% YoY), net loss $22.3M, raises FY23 guidance","bullets":["Net sales $86.3M (+14% YoY); consumables +21% YoY led by Americas +34% and EMEA +35% ex-Russia.","Net loss $22.3M vs net income $31.5M in prior year; adjusted EBITDA loss $0.5M vs +$1.2M.","GAAP gross margin 62.7% (down from 67.5%); adjusted gross margin 70.0% (down from 71.3%).","Company raises FY2023 net sales guidance and reaffirms EBITDA margin and 2025 long-term targets.","Syndeo international launch planned for Q2 2023; China COVID shutdowns affected Jan-Feb but rebound in March."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-017025","json":"https://secwatch.observer/filing/0001628280-23-017025.json","markdown":"https://secwatch.observer/filing/0001628280-23-017025.md","text":"https://secwatch.observer/filing/0001628280-23-017025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818093/000162828023017025/0001628280-23-017025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818093/000162828023017025/skin-20230510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T06:56:26.511586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"100a9a735f2db40300321fd28f90c7af4a7cdf04","claim":"SkinHealth Systems Inc. reported the first quarter ended March 31, 2023 results: revenue $86.3 million, net income $(22.3) million. Guidance raised.","evidence_excerpt":"BeautyHealth Reports First Quarter 2023 Financial Results On strong consumer demand, delivers double-digit net sales growth in line with 2023 plan Raises fiscal 2023 net sales guidance Long Beach, Calif., May 10, 2023 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2023. For the quarter, net sales of $86.3 million increased +14% year-over-year, continuing a trend of double-digit quarterly growth. On the momentum, the Company raises 2023 net sales guidance and reaffirms 2023 EBITDA margin and 2025 long-term targets. The quarter was underpinned by continued strong consumer demand for Hydrafacial treatments, with +21% year-over-year consumables net sales growth globally. Of note, consumables net sales grew +34% year-over-year in the Americas and +13% in EMEA. Excluding $1.2 million of Q1 2022 consumables net sales in Russia, growth in EMEA was +35%. In APAC, consumables net sales declin","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828023017025/0001628280-23-017025-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Revenue","value":"$86.3 million"},{"label":"Net income","value":"$(22.3) million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}